1022 related articles for article (PubMed ID: 16338281)
1. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
3. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application.
Plangger N; Rist L; Zimmermann R; von Mandach U
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):168-72. PubMed ID: 16051414
[TBL] [Abstract][Full Text] [Related]
5. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
Rozenberg P
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
[TBL] [Abstract][Full Text] [Related]
6. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.
Eisenach JH; McGuire AM; Schwingler RM; Turner ST; Joyner MJ
Physiol Genomics; 2004 Feb; 16(3):323-8. PubMed ID: 14665698
[TBL] [Abstract][Full Text] [Related]
7. The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor.
Bisits A; Madsen G; Knox M; Gill A; Smith R; Yeo G; Kwek K; Daniel M; Leung TN; Cheung K; Chung T; Jones I; Toohill J; Tudehope D; Giles W
Am J Obstet Gynecol; 2004 Sep; 191(3):683-90. PubMed ID: 15467526
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
[TBL] [Abstract][Full Text] [Related]
9. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
[TBL] [Abstract][Full Text] [Related]
10. beta2-Adrenergic receptor genotype and preterm delivery.
Landau R; Xie HG; Dishy V; Stein CM; Wood AJ; Emala CW; Smiley RM
Am J Obstet Gynecol; 2002 Nov; 187(5):1294-8. PubMed ID: 12439523
[TBL] [Abstract][Full Text] [Related]
11. Beta2-adrenergic receptor gene polymorphisms and pregnancy outcome.
Doh K; Sziller I; Vardhana S; Kovacs E; Papp Z; Witkin SS
J Perinat Med; 2004; 32(5):413-7. PubMed ID: 15493717
[TBL] [Abstract][Full Text] [Related]
12. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJ
N Engl J Med; 2001 Oct; 345(14):1030-5. PubMed ID: 11586955
[TBL] [Abstract][Full Text] [Related]
13. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation.
Elliott JP; Istwan NB; Rhea DJ; Desch CN; Stanziano GJ
Am J Perinatol; 2009 Feb; 26(2):123-8. PubMed ID: 18850519
[TBL] [Abstract][Full Text] [Related]
14. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.
Sciscione AC; Stamilio DM; Manley JS; Shlossman PA; Gorman RT; Colmorgen GH
Am J Perinatol; 1998 Mar; 15(3):177-81. PubMed ID: 9572373
[TBL] [Abstract][Full Text] [Related]
15. Behaviour of beta 2-adrenoceptors on lymphocytes under continuous and pulsatile tocolysis with Fenoterol.
Schmidt-Rhode P; Brunke B; Schröer H; Obert K; Schlegel K; Sturm G; Schulz KD; von Wichert P
J Perinat Med; 2003; 31(1):47-51. PubMed ID: 12661144
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
17. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
[TBL] [Abstract][Full Text] [Related]
18. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
19. Tocolysis with the β-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants.
Mayer M; Minichmayr A; Klement F; Hroncek K; Wertaschnigg D; Arzt W; Wiesinger-Eidenberger G; Lechner E
Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F108-11. PubMed ID: 22611112
[TBL] [Abstract][Full Text] [Related]
20. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
